Livmarli
Chemical Name | maralixibat |
Dosage Form | Solution (oral; 9.5 mg/mL) |
Drug Class | Inhibitors |
System | Digestive |
Company | Mirum Pharmaceuticals |
Approval Year | 2021 |
Indication
- For the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 1 year of age and older